{
  "id": 8039782,
  "title": "Cathie Wood’s ARK increases stake in Guardant Health stock",
  "url": "https://urgent.news/2026/09/17/cathie-woods-ark-increases-stake-in-guardant-health-stock",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-09-17T14:34:12.000Z",
  "source": {
    "name": "Investing.com",
    "slug": "investing-com",
    "url": "https://www.investing.com/news/company-news/cathie-woods-ark-increases-stake-in-guardant-health-stock-93CH-4905995"
  },
  "original_language": "en",
  "account": "On Thursday, September 17th, 2026, ARK ETF led by Cathie Wood announced a shift in its investment strategy, focusing on Guardant Health Inc. (NASDAQ:GH) and other strategic acquisitions. The most significant transaction was the purchase of 7,738 shares of Guardant Health, valued at $1,353,376 through ARKG ETF, indicating a strong confidence in the healthcare sector. This move follows a pattern of increasing stake in Guardant Health, which ARK has pursued over the past week. Additionally, ARK added 293 shares of Scribe Therapeutics Inc (SCTX), valued at $8,526, further demonstrating its continued interest in the biotech industry. On the selling side, ARK reduced its holdings in Brera Holdings PLC (SLMT) by 1,432 shares, amounting to $4,381, as part of its ongoing portfolio adjustments. Overall, these transactions underscore ARK's strategic pivot towards healthcare and biotechnology, reflecting a belief in the growth potential of these industries.",
  "summary": null,
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}